MOSCOW (Reuters) – Russia’s sovereign wealth fund said on Wednesday it had signed a deal to provide Mexican pharmaceutical firm Landsteiner Scientific with 32 million doses of the Russian-produced COVID-19 vaccine “Sputnik-V”, the fund said in a assertion.
Deliveries of the vaccine to Mexico are anticipated to delivery in November, pending approval by Mexican regulators, the Russian Bid Investment Fund (RDIF) said.
Russian regulators licensed the vaccine for domestic employ in early August after initial, diminutive-scale human trials. It’s some distance in the meantime being examined on 40,000 other folks in Russia in a trial that launched on Aug. 26.
Mexico’s Landsteiner Scientific will additionally distribute the vaccine, RDIF said.
“Now we private agreed to insist the remarkable batch of Sputnik-V vaccine to Mexico, which is able to assist 25% of the Mexican population to salvage procure admission to to the genuine and efficient vaccine,” RDIF head Kirill Dmitriev said.
Mexico had previously suggested Moscow it turned into once wanting to attain tiresome-stage testing of the Russian-produced vaccine. It has already agreed to attain trials of vaccines developed by U.S. firm Johnson & Johnson and two Chinese companies.
RDIF, which is backing the vaccine’s pattern, signed its first export deal with Kazakhstan in August. Kazakhstan is set of dwelling to map terminate greater than 2 million doses on the starting up and can later enhance the volume to 5 million doses, RDIF said on the time.
